Patent ID: 11951115
Assignee: UNITY BIOTECHNOLOGY, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating a patient suffering from a retinal vasculopathy comprising administering to the patient a therapeutically effective dose of a meglumine salt of a compound of Formula I (Compound-meglumine):, , (R)-5-(4-chlorophenyl)-1-isopropyl-2-methyl-4-(3-(4-(4-((4-((1-(phenylthio)-4-(4-((phosphonooxy)methyl)piperidin-1-yl)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonamido)phenyl)piperazin-1-yl)phenyl)-1H-pyrrole-3-carboxylic acid,, wherein the therapeutically effective dose is up to 10 ug of the Compound-meglumine is administered intravitreally (IVT) per eye.